Dual HDAC and PI3K Inhibitor: A Novel Potential Therapeutic Option in Cushing Disease.
Citation: Journal of Clinical Endocrinology & Metabolism. 106(2):e1036-e1038, 2021 01 23.PMID: 33205152Institution: MedStar Washington Hospital CenterDepartment: Medicine/EndocrinologyForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: *Phosphatidylinositol 3-Kinases | *Pituitary ACTH Hypersecretion | Histone Deacetylase Inhibitors/tu [Therapeutic Use] | Humans | Phosphoinositide-3 Kinase Inhibitors | Pituitary ACTH Hypersecretion/dt [Drug Therapy]Year: 2021Local holdings: Available online through MWHC library: 1999- June 2013, Available in print through MWHC library: 1999 - 2006ISSN:- 0021-972X
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 33205152 | Available | 33205152 |
Available online through MWHC library: 1999- June 2013, Available in print through MWHC library: 1999 - 2006
English